1yoj

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /> <applet load="1yoj" size="450" color="white" frame="true" align="right" spinBox="true" caption="1yoj, resolution 1.95&Aring;" /> '''Crystal structure o...)
Line 1: Line 1:
-
[[Image:1yoj.gif|left|200px]]<br />
+
[[Image:1yoj.gif|left|200px]]<br /><applet load="1yoj" size="350" color="white" frame="true" align="right" spinBox="true"
-
<applet load="1yoj" size="450" color="white" frame="true" align="right" spinBox="true"
+
caption="1yoj, resolution 1.95&Aring;" />
caption="1yoj, resolution 1.95&Aring;" />
'''Crystal structure of Src kinase domain'''<br />
'''Crystal structure of Src kinase domain'''<br />
==Overview==
==Overview==
-
c-Src was the first proto-oncoprotein to be identified, and has become the, focus of many drug discovery programs. Src structures of a major inactive, form have shown how the protein kinase is rigidified by several, interdomain interactions; active configurations of Src are generated by, release from this "assembled" or "bundled" form. Despite the importance of, Src as a drug target, there is relatively little structural information, available regarding the presumably more flexible active forms. Here we, report three crystal structures of a dimeric active c-Src kinase domain, in an apo and two ligand complexed forms, with resolutions ranging from, 2.9A to 1.95A. The structures show how the kinase domain, in the absence, of the rigidifying interdomain interactions of the inactivation state, adopts a more open and flexible conformation. The ATP site inhibitor, CGP77675 binds to the protein kinase with canonical hinge hydrogen bonds, and also to the c-Src specific threonine 340. In contrast to purvalanol B, binding in CDK2, purvalanol A binds in c-Src with a conformational change, in a more open ATP pocket.
+
c-Src was the first proto-oncoprotein to be identified, and has become the focus of many drug discovery programs. Src structures of a major inactive form have shown how the protein kinase is rigidified by several interdomain interactions; active configurations of Src are generated by release from this "assembled" or "bundled" form. Despite the importance of Src as a drug target, there is relatively little structural information available regarding the presumably more flexible active forms. Here we report three crystal structures of a dimeric active c-Src kinase domain, in an apo and two ligand complexed forms, with resolutions ranging from 2.9A to 1.95A. The structures show how the kinase domain, in the absence of the rigidifying interdomain interactions of the inactivation state, adopts a more open and flexible conformation. The ATP site inhibitor CGP77675 binds to the protein kinase with canonical hinge hydrogen bonds and also to the c-Src specific threonine 340. In contrast to purvalanol B binding in CDK2, purvalanol A binds in c-Src with a conformational change in a more open ATP pocket.
==Disease==
==Disease==
Line 11: Line 10:
==About this Structure==
==About this Structure==
-
1YOJ is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Active as [http://en.wikipedia.org/wiki/Transferase Transferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.10.1 and 2.7.10.2 2.7.10.1 and 2.7.10.2] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1YOJ OCA].
+
1YOJ is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Active as [http://en.wikipedia.org/wiki/Transferase Transferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.10.1 and 2.7.10.2 2.7.10.1 and 2.7.10.2] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1YOJ OCA].
==Reference==
==Reference==
Line 18: Line 17:
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Transferase]]
[[Category: Transferase]]
-
[[Category: Breitenlechner, C.B.]]
+
[[Category: Breitenlechner, C B.]]
-
[[Category: Engh, R.A.]]
+
[[Category: Engh, R A.]]
[[Category: Greiter, E.]]
[[Category: Greiter, E.]]
[[Category: Honold, K.]]
[[Category: Honold, K.]]
[[Category: Huber, R.]]
[[Category: Huber, R.]]
-
[[Category: Kairies, N.A.]]
+
[[Category: Kairies, N A.]]
[[Category: Koch, S.]]
[[Category: Koch, S.]]
[[Category: Koll, H.]]
[[Category: Koll, H.]]
Line 30: Line 29:
[[Category: protein tyrosine kinase]]
[[Category: protein tyrosine kinase]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 20:22:16 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 16:07:31 2008''

Revision as of 14:07, 21 February 2008


1yoj, resolution 1.95Å

Drag the structure with the mouse to rotate

Crystal structure of Src kinase domain

Contents

Overview

c-Src was the first proto-oncoprotein to be identified, and has become the focus of many drug discovery programs. Src structures of a major inactive form have shown how the protein kinase is rigidified by several interdomain interactions; active configurations of Src are generated by release from this "assembled" or "bundled" form. Despite the importance of Src as a drug target, there is relatively little structural information available regarding the presumably more flexible active forms. Here we report three crystal structures of a dimeric active c-Src kinase domain, in an apo and two ligand complexed forms, with resolutions ranging from 2.9A to 1.95A. The structures show how the kinase domain, in the absence of the rigidifying interdomain interactions of the inactivation state, adopts a more open and flexible conformation. The ATP site inhibitor CGP77675 binds to the protein kinase with canonical hinge hydrogen bonds and also to the c-Src specific threonine 340. In contrast to purvalanol B binding in CDK2, purvalanol A binds in c-Src with a conformational change in a more open ATP pocket.

Disease

Known disease associated with this structure: Colon cancer, advanced OMIM:[190090]

About this Structure

1YOJ is a Single protein structure of sequence from Homo sapiens. Active as Transferase, with EC number and 2.7.10.2 2.7.10.1 and 2.7.10.2 Full crystallographic information is available from OCA.

Reference

Crystal structures of active SRC kinase domain complexes., Breitenlechner CB, Kairies NA, Honold K, Scheiblich S, Koll H, Greiter E, Koch S, Schafer W, Huber R, Engh RA, J Mol Biol. 2005 Oct 21;353(2):222-31. PMID:16168436

Page seeded by OCA on Thu Feb 21 16:07:31 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools